Sodium Tetradecyl Sulphate

An ion exchange resin used in the treatment of high plasma potassium levels (hyperkalemia) where it exchanges sodium ions for potassium and other cations in the Git following oral or rectal administration. Serum electrolyte concentration should be monitored during the course of treatment with the drug.

Brands
Adult Dose
Dose: 0.5 to 2 mL
Single Dose: 1.2 (1.25)
Frequency: As recommended.
Route: IV
Instructions:
Neonatal
Paedriatic
Characteristics
. It is of Synthetic origin. . The Molecular Weight of Sodium Tetradecyl Sulphate is 316.44. It is weakly acidic drug.
Contraindications
Sodium Tetradecyl Sulphate is contraindicated in conditions like Cellulitis,Hypersensitivity,Non-ambulatory patient,Venous inflammation.
Effects
The severe or irreversible adverse effects of Sodium Tetradecyl Sulphate, which give rise to further complications include Ulceration, Tissue necrosis, Chest pain, Reflex esophagitis.Sodium Tetradecyl Sulphate produces potentially life-threatening effects which include Asthma, Anaphylactic reactions, Gangrene of limbs, Hay fever, Ischemic damage, Hives. which are responsible for the discontinuation of Sodium Tetradecyl Sulphate therapy.The symptomatic adverse reactions produced by Sodium Tetradecyl Sulphate are more or less tolerable and if they become severe, they can be treated symptomatically, these include Headache, Nausea, Vomiting.
Indications
Sodium Tetradecyl Sulphate is primarily indicated in conditions like Hydrocele, Peptic ulcer bleeding, Variceal bleeding, Varicose veins.
Interactions
No data regarding the interactions of Sodium Tetradecyl Sulphate was found.
Interfrence
Risks
Drug should not be given to Pregnant Mothers.If prescribing authority justifies the benefits of the drug against the possible damages he/she should reevaluate them and consult the reference material and previous studies.
Storage
IV Inj Store Between 20°C-25°C. Protect from Sunlight.
Warnings
Extreme caution must be exercised in the presence of underlying arterial disease such as marked peripheral arteriosclerosis or thromboangiitis obliterans. Should be given to a pregnant woman only if clearly needed and the benefits outweigh the risks. It is not known whether this drug is excreted in human milk. Because many drugs are excreted in human milk, caution should be exercised when administered to a nursing woman.
Back to List

Any information that appears on this website page is provided for the purpose of general information. This website has been compiled in good faith by HMIS.Online. However, no guarantee is made as to the completeness, validity or accuracy of the information it contains.